Clinical valve thrombosis after transcatheter aortic valve-in-valve implantation is common (7.6%) and is significantly associated with the absence of oral anticoagulation therapy.
No takes yet. Share an insight, caveat, or question.
Clinical ViV thrombosis warrants heightened post-procedural surveillance without anticoagulation; leaves open optimal regimens for randomized evaluation.
Abdel‐Wahab et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: